Cargando…
Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study
BACKGROUND: In Rwanda, epidemiological data characterizing people who inject drugs (PWID) and their burden of HIV are limited. We examined injection drug use (IDU) history and practices, and HIV infection in a sample of PWID in Kigali. METHODS: From October 2019 to February 2020, 307 PWID aged ≥ 18...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672501/ https://www.ncbi.nlm.nih.gov/pubmed/34911554 http://dx.doi.org/10.1186/s12954-021-00579-0 |
_version_ | 1784615366846054400 |
---|---|
author | Twahirwa Rwema, Jean Olivier Nizeyimana, Vianney Prata, Neia M. Okonkwo, Nneoma E. Mazzei, Amelia A. Muhirwa, Sulemani Rukundo, Athanase Lucas, Lisa Niyigena, Audace Makuza, Jean Damascene Beyrer, Chris Baral, Stefan D. Kagaba, Aflodis |
author_facet | Twahirwa Rwema, Jean Olivier Nizeyimana, Vianney Prata, Neia M. Okonkwo, Nneoma E. Mazzei, Amelia A. Muhirwa, Sulemani Rukundo, Athanase Lucas, Lisa Niyigena, Audace Makuza, Jean Damascene Beyrer, Chris Baral, Stefan D. Kagaba, Aflodis |
author_sort | Twahirwa Rwema, Jean Olivier |
collection | PubMed |
description | BACKGROUND: In Rwanda, epidemiological data characterizing people who inject drugs (PWID) and their burden of HIV are limited. We examined injection drug use (IDU) history and practices, and HIV infection in a sample of PWID in Kigali. METHODS: From October 2019 to February 2020, 307 PWID aged ≥ 18 were enrolled in a cross-sectional study using convenience sampling in Kigali. Participants completed interviewer-administered questionnaires on IDU history and practices and HIV testing. We used Poisson regression with robust variance estimation to assess IDU practices associated with HIV infection and assessed factors associated with needle sharing in the six months preceding the study. RESULTS: The median age was 28 years (IQR 24–31); 81% (251) were males. Female PWID were more likely to report recent IDU initiation, selling sex for drugs, and to have been injected by a sex partner (p < 0.05). In the prior six months, heroin was the primary drug of choice for 99% (303) of participants, with cocaine and methamphetamine also reported by 10% (31/307) and 4% (12/307), respectively. In total, 91% (280/307) of participants reported ever sharing needles in their lifetime and 43% (133) knew someone who died from a drug-related overdose. HIV prevalence was 9.5% (95% CI 8.7–9.3). Sharing needles at least half of the time in the previous six months was positively associated with HIV infection (adjusted prevalence ratio (aPR) 2.67; 95% CI 1.23–5.78). Overall, 31% (94/307) shared needles and 33% (103/307) reused needles in the prior six months. Female PWID were more likely to share needles compared to males (aPR 1.68; 95% CI 1.09–2.59). Additionally, bisexual PWID (aPR 1.68; 95% CI 1.09–2.59), those who shared needles at the first injection (aPR 2.18; 95% CI 1.59–2.99), reused needles recently (aPR 2.27; 95% CI 1.51–3.43) and shared other drug paraphernalia (aPR 3.56; 95% CI 2.19–5.81) were more likely to report recent needle sharing. CONCLUSION: HIV infection was common in this study. The high prevalence of needle reuse and sharing practices highlights significant risks for onward transmission and acquisition of HIV and viral hepatitis. These data highlight the urgent need for PWID-focused harm reduction services in Rwanda, including syringe services programs, safe injection education, naloxone distribution, and substance use disorder treatment programs and optimizing these services to the varied needs of people who use drugs in Rwanda. |
format | Online Article Text |
id | pubmed-8672501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86725012021-12-15 Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study Twahirwa Rwema, Jean Olivier Nizeyimana, Vianney Prata, Neia M. Okonkwo, Nneoma E. Mazzei, Amelia A. Muhirwa, Sulemani Rukundo, Athanase Lucas, Lisa Niyigena, Audace Makuza, Jean Damascene Beyrer, Chris Baral, Stefan D. Kagaba, Aflodis Harm Reduct J Research BACKGROUND: In Rwanda, epidemiological data characterizing people who inject drugs (PWID) and their burden of HIV are limited. We examined injection drug use (IDU) history and practices, and HIV infection in a sample of PWID in Kigali. METHODS: From October 2019 to February 2020, 307 PWID aged ≥ 18 were enrolled in a cross-sectional study using convenience sampling in Kigali. Participants completed interviewer-administered questionnaires on IDU history and practices and HIV testing. We used Poisson regression with robust variance estimation to assess IDU practices associated with HIV infection and assessed factors associated with needle sharing in the six months preceding the study. RESULTS: The median age was 28 years (IQR 24–31); 81% (251) were males. Female PWID were more likely to report recent IDU initiation, selling sex for drugs, and to have been injected by a sex partner (p < 0.05). In the prior six months, heroin was the primary drug of choice for 99% (303) of participants, with cocaine and methamphetamine also reported by 10% (31/307) and 4% (12/307), respectively. In total, 91% (280/307) of participants reported ever sharing needles in their lifetime and 43% (133) knew someone who died from a drug-related overdose. HIV prevalence was 9.5% (95% CI 8.7–9.3). Sharing needles at least half of the time in the previous six months was positively associated with HIV infection (adjusted prevalence ratio (aPR) 2.67; 95% CI 1.23–5.78). Overall, 31% (94/307) shared needles and 33% (103/307) reused needles in the prior six months. Female PWID were more likely to share needles compared to males (aPR 1.68; 95% CI 1.09–2.59). Additionally, bisexual PWID (aPR 1.68; 95% CI 1.09–2.59), those who shared needles at the first injection (aPR 2.18; 95% CI 1.59–2.99), reused needles recently (aPR 2.27; 95% CI 1.51–3.43) and shared other drug paraphernalia (aPR 3.56; 95% CI 2.19–5.81) were more likely to report recent needle sharing. CONCLUSION: HIV infection was common in this study. The high prevalence of needle reuse and sharing practices highlights significant risks for onward transmission and acquisition of HIV and viral hepatitis. These data highlight the urgent need for PWID-focused harm reduction services in Rwanda, including syringe services programs, safe injection education, naloxone distribution, and substance use disorder treatment programs and optimizing these services to the varied needs of people who use drugs in Rwanda. BioMed Central 2021-12-15 /pmc/articles/PMC8672501/ /pubmed/34911554 http://dx.doi.org/10.1186/s12954-021-00579-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Twahirwa Rwema, Jean Olivier Nizeyimana, Vianney Prata, Neia M. Okonkwo, Nneoma E. Mazzei, Amelia A. Muhirwa, Sulemani Rukundo, Athanase Lucas, Lisa Niyigena, Audace Makuza, Jean Damascene Beyrer, Chris Baral, Stefan D. Kagaba, Aflodis Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study |
title | Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study |
title_full | Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study |
title_fullStr | Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study |
title_full_unstemmed | Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study |
title_short | Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study |
title_sort | injection drug use practices and hiv infection among people who inject drugs in kigali, rwanda: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672501/ https://www.ncbi.nlm.nih.gov/pubmed/34911554 http://dx.doi.org/10.1186/s12954-021-00579-0 |
work_keys_str_mv | AT twahirwarwemajeanolivier injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT nizeyimanavianney injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT prataneiam injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT okonkwonneomae injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT mazzeiameliaa injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT muhirwasulemani injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT rukundoathanase injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT lucaslisa injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT niyigenaaudace injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT makuzajeandamascene injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT beyrerchris injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT baralstefand injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy AT kagabaaflodis injectiondrugusepracticesandhivinfectionamongpeoplewhoinjectdrugsinkigalirwandaacrosssectionalstudy |